Biomarkers and immunotherapy: where are we?
Authors : Langouo Fontsa M, Padonou F, Willard-Gallo K
Year : 2022
Journal : Curr Opin Oncol
Volume : 34
Pages : 579-586
Molecular oncology: what is needed to speed access to innovative therapies in clinical research?
Authors : Gourari K, Awada A, Kotecki N
Year : 2022
Journal : Curr Opin Oncol
Volume : 34
Pages : 575-578
Cancer epitranscriptomics in a nutshell.
Authors : Primac I, Penning A, Fuks F
Year : 2022
Journal : Curr Opin Genet Dev
Volume : 75
Pages : 101924
An impact model to understand and improve work-life balance in early-career researchers in radiation oncology.
Authors : Pittens C, Dhont J, Petit S, Dubois L, Franco P, Mullaney L, Aznar M, Petit-Steeghs V, Bertholet J
Year : 2022
Journal : Clin Transl Radiat Oncol
Volume : 37
Pages : 101-108
Empiric versus pre-emptive antifungal strategy in high-risk neutropenic patients on fluconazole prophylaxis: a randomized trial of the European organization for Research and Treatment of cancer (EORTC 65091).
Authors : Maertens J, Lodewyck T, Peter Donnelly J, Chantepie S, Robin C, Blijlevens N, Turlure P, Selleslag D, Baron F, Aoun M, Heinz WJ, Bertz H, Vandercam B, Drgona L, Coiteux V, Llorente CC, Schaefer-Prokop C, Paesmans M, Ameye L, Meert L, Cheung KJ, Hepler DA, Loeffler J, Barnes R, Marchetti O, Verweij P, Lamoth F, Bochud PY, Schwarzinger M, Cordonnier C
Year : 2022
Journal : Clin Infect Dis
Volume : 76
Pages : 674-82
Effectiveness and Safety of Ibrutinib for Chronic Lymphocytic Leukemia in Routine Clinical Practice: 3-Year Follow-up of the Belgian Ibrutinib Real-World Data (BiRD) Study.
Authors : Janssens A, Berneman ZN, Offner F, Snauwaert S, Mineur P, Vanstraelen G, Meers S, Spoormans I, Bron D, Vande Broek I, Van Bogaert C, De Beleyr B, Smet A, Nielsen L, Wapenaar R, André M
Year : 2022
Journal : Clin Hematol Int
Volume : 4
Pages : 133-143
Morphological evaluation of melanocytic lesions with three-dimensional line-field confocal optical coherence tomography: correlation with histopathology and reflectance confocal microscopy. A pilot study.
Authors : Perez-Anker J, Puig S, Alos L, García A, Alejo B, Cinotti E, Orte Cano C, Tognetti L, Lenoir C, Monnier J, Machuca N, Castillo P, Gibert PR, Rubegni P, Suppa M, Perrot JL, Del Marmol V, Malvehy J
Year : 2022
Journal : Clin Exp Dermatol
Volume : 47
Pages : 2222-2233
Highlights from the 2022 ASCO gastrointestinal cancer symposium: An overview by the EORTC gastrointestinal tract cancer group.
Authors : Sclafani F, Fontana E, Wyrwicz L, Wagner AD, Valle JW, Smyth E, Peeters M, Obermannova R, Neuzillet C, Lutz MP, Koessler T, Ben-Aharon I, Arnold D, Alsina M, Moehler M
Year : 2022
Journal : Clin Colorectal Cancer
Volume : 21
Pages : 188-197
Unresectable and chemoresistant conjunctival squamous cell carcinoma on xeroderma pigmentosum treated by salvage radiation therapy: A case report and a review of the literature.
Authors : Maimouna M, Sofian B, Latifatou G, Joséphine Frédérique Mendouga E, Papa Macoumba G, Mamadou Moustapha D, Dirk VG
Year : 2022
Journal : Clin Case Rep
Volume : 10
Pages : e6360
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors.
Authors : Kim TW, Burris HA, de Miguel Luken MJ, Pishvaian MJ, Bang YJ, Gordon M, Awada A, Camidge DR, Hodi FS, McArthur GA, Miller WH, Cervantes A, Chow LQ, Lesokhin AM, Rutten A, Sznol M, Rishipathak D, Chen SC, Stefanich E, Pourmohamad T, Anderson M, Kim J, Huseni M, Rhee I, Siu LL
Year : 2022
Journal : Clin Cancer Res
Volume : 28
Pages : 3452-3463
Disease Behavior and Treatment Response of Special Histological Types of Triple-Negative Breast Cancer.
Authors : Bonadio RC, Costa FA, Mendes SV, Araujo BJ, Nader-Marta G, Pinto PBC, Batista DN, Testa L, Ferrari MS
Year : 2022
Journal : Clin Breast Cancer
Volume : 22
Pages : e892-e900
Immunoscore Combining CD8, FoxP3, and CD68-Positive Cells Density and Distribution Predicts the Prognosis of Head and Neck Cancer Patients.
Authors : Furgiuele S, Descamps G, Lechien JR, Dequanter D, Journe F, Saussez S
Year : 2022
Journal : Cells
Volume : 11
Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer.
Authors : Schettini F, Venturini S, Giuliano M, Lambertini M, Pinato DJ, Onesti CE, De Placido P, Harbeck N, Lüftner D, Denys H, Van Dam P, Arpino G, Zaman K, Mustacchi G, Gligorov J, Awada A, Campone M, Wildiers H, Gennari A, Tjan-Heijnen V, Bartsch R, Cortes J, Paris I, Martín M, De Placido S, Del Mastro L, Jerusalem G, Curigliano G, Prat A, Generali D
Year : 2022
Journal : Cancer Treat Rev
Volume : 111
Pages : 102468
Regorafenib in combination with immune checkpoint inhibitors for mismatch repair proficient (pMMR)/microsatellite stable (MSS) colorectal cancer.
Authors : Akin Telli T, Bregni G, Vanhooren M, Saude Conde R, Hendlisz A, Sclafani F
Year : 2022
Journal : Cancer Treat Rev
Volume : 110
Pages : 102460
When targeted therapy for cancer leads to ICU admission. RETRO-TARGETICU multicentric study.
Authors : Meert AP, Toffart AC, Picard M, Jaubert P, Gibelin A, Bauer P, Mokart D, Van de Louw A, Hatzl S, Moreno-Gonzales G, Rousseau-Bussac G, Bruneel F, Montini L, Moreau AS, Carpentier D, Seguin A, Hemelaar P, Azoulay E, Lemiale V
Year : 2022
Journal : Bull Cancer
Volume : 109
Pages : 916-924
Long term outcome data from the EORTC 75111-10114 ETF/BCG randomized phase II study: Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer, followed by T-DM1 after progressio
Authors : Wildiers H, Meyskens T, Marréaud S, Lago LD, Vuylsteke P, Curigliano G, Waters S, Brouwers B, Meulemans B, Sousa B, Poncet C, Brain E
Year : 2022
Journal : Breast
Volume : 64
Pages : 100-111
Outcomes of patients with small and node-negative HER2-positive early breast cancer treated with adjuvant chemotherapy and anti-HER2 therapy-a sub-analysis of the ALTTO study.
Authors : Nader-Marta G, Debien V, Eiger D, Tsourti Z, Caparica R, Kassapian M, Napoleone S, Hultsch S, Korde L, Wang Y, Chumsri S, Pritchard KI, Untch M, Bellet-Ezquerra M, Dornelles Rosa D, Moreno-Aspitia A, Piccart M, Dafni U, de Azambuja E
Year : 2022
Journal : Br J Cancer
Volume : 127
Pages : 1799-1807
Use of information and communication technologies (ICTs) in cancer multidisciplinary team meetings: an explorative study based on EU healthcare professionals.
Authors : Prades J, Coll-Ortega C, Dal Lago L, Goffin K, Javor E, Lombardo C, de Munter J, Ponce J, Regge D, Salazar R, Valentini V, Borras JM
Year : 2022
Journal : BMJ Open
Volume : 12
Pages : e051181
Cytokine Landscape in Central Nervous System Metastases.
Authors : Marin J, Journe F, Ghanem GE, Awada A, Kindt N
Year : 2022
Journal : Biomedicines
Volume : 10
Comments on The Impact of Neoadjuvant Chemotherapy on the Surgical Management of Colorectal Peritoneal Metastases: A Systematic Review and Meta-analysis"."
Authors : Liberale G, Moreau M, Repullo D
Year : 2022
Journal : Ann Surg Oncol
Volume : 29
Pages : 7933-7934